Markets

Market

News Details

(15/12/2025 10:00)

Corona Remedies Ltd. debuts with 36.72% premium at Rs 1,452.00

Corona Remedies Ltd. makes a strong debut on the bourses with scrip got listed at Rs 1,452.00 on the Bombay Stock Exchange, a 36.72 per cent premium to its issue price of Rs 1,062.00. On the National Stock Exchange, the stock was listed at Rs 1,470.00.

The company, which raised 0.62 Cr from initial public offering, was subscribed 0 times, receiving bids for 0 lakhs shares against the total issue size of 61.71 lakhs shares.

The company, listed under B Group Securities post its IPO, opened for subscription from Dec 08 to Dec 10.

Following a strong opening, the scrip touched an intraday high of Rs [BSEHighPrice] and a low of Rs [NSEHighPrice], before closing the session [UpDown] by [ChangePer] per cent to its listing price at Rs [ClosingPriceBSE] on the BSE.

The company anticipates using the proceeds of the issue for .

Kotak Mahindra Capital Company Limited,JM Financial Limited,IIFL Capital Services Limited as lead managers & Bigshare Services Pvt. Ltd. is the registrar, to the issue.

Meanwhile, the broader benchmark BSE Sensex closed trade at 85,267.66, up 449.53 points, or 0.52 per cent.

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remain in investor's account.